Chemomab Therapeutics (CMMB) Leases (2019 - 2025)
Chemomab Therapeutics posted quarterly Leases of $264000.0 for Q1 2025, down 28.07% year-on-year from $367000.0 in Q1 2024, and down 8.65% on a QoQ basis from $289000.0 in Q4 2024.
Chemomab Therapeutics (CMMB) has 7 years of Leases data on file, last reported at $264000.0 in Q1 2025.
- For the quarter ending Q1 2025, Leases fell 28.07% year-over-year to $264000.0; the trailing twelve-month figure through Mar 2025 stood at $264000.0 (down 28.07% YoY), and the FY2024 full-year result was $289000.0, down 26.28% from the prior year.
- Leases for Q1 2025 stood at $264000.0, down from $289000.0 in the prior quarter.
- Across five years, Leases topped out at $397000.0 in Q1 2021 and bottomed at $130000.0 in Q3 2023.
- The 5-year median for Leases is $309000.0 (2022), against an average of $296235.3.
- The widest annual swing landed in 2023, when Leases plunged 50.19%; it then jumped 142.31% in 2024.
- A 5-year view of Leases shows it stood at $345000.0 in 2021, then tumbled by 34.2% to $227000.0 in 2022, then surged by 72.69% to $392000.0 in 2023, then fell by 26.28% to $289000.0 in 2024, then fell by 8.65% to $264000.0 in 2025.
- The last three Leases figures came in at $264000.0 (Q1 2025), $289000.0 (Q4 2024), and $315000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 264,000.00 |
| Dec 31, 2024 | 289,000.00 |
| Sep 30, 2024 | 315,000.00 |
| Jun 30, 2024 | 341,000.00 |
| Mar 31, 2024 | 367,000.00 |
| Dec 31, 2023 | 392,000.00 |
| Sep 30, 2023 | 130,000.00 |
| Jun 30, 2023 | 160,000.00 |
| Mar 31, 2023 | 193,000.00 |
| Dec 31, 2022 | 227,000.00 |
| Sep 30, 2022 | 261,000.00 |
| Jun 30, 2022 | 295,000.00 |
| Mar 31, 2022 | 309,000.00 |
| Dec 31, 2021 | 345,000.00 |
| Sep 30, 2021 | 359,000.00 |
| Jun 30, 2021 | 392,000.00 |
| Mar 31, 2021 | 397,000.00 |
| Dec 31, 2020 | 428,000.00 |
| Sep 30, 2020 | 234,000.00 |
| Jun 30, 2020 | 275,000.00 |
| Mar 31, 2020 | 339,000.00 |
| Dec 31, 2019 | 1.20 Mn |
| Sep 30, 2019 | 1.57 Mn |
| Jun 30, 2019 | 1.60 Mn |